SCHEMBL347023

SCHEMBL347023

O=C(Cl)CCCCCCCCCCBr

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.56
ALDH1A1 P00352 2/20 0.56
TP53 P04637 1/20 0.48
LMNA P02545 3/20 0.36
NFKB1 P19838 1/20 0.36
PMP22 Q01453 1/20 0.36
FAAH O00519 1/20 0.34
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
MAPT P10636 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CES2 O00748 3/20 0.31
CES1 P23141 3/20 0.31
GPR84 Q9NQS5 1/20 0.31
FFAR1 O14842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348782 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL306578 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL347793 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL11255873 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL13859605 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL34211 1.00
SCHEMBL347787 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL305763 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL349064 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL28244416 1.00 TSHR (0.56) TSHRALDH1A1TP53LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108484687-A The preparation method of technetium-99 m labeled triphenylphosphine salt derivative and application 河南中医药大学 2018-09-04 CN claimed
EP-0711746-A1 Process for preparing hydroxycarboxylic acids UNILEVER PLC (GB) 1996-05-15 EP claimed
US-5502226-A SELECTIVE REDUCTION OF DIKETONE TO KETO ACIDS USING HYDROGEN IN THE PRESENCE OF BASE ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) 1996-03-26 US claimed
WO-2025047909-A1 PROTAC COMPOUND 国立大学法人東北大学 2025-03-06 WO disclosed
US-12103909-B2 Polycyclic aromatic hydrocarbon-based compounds for molecular electronic device and molecular electronic devices comprising same KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2024-10-01 US disclosed
EP-4119598-A1 NANOCOMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS Nanocore ApS (DK) 2023-01-18 EP disclosed
CN-112707900-B Protein degrading agents and their use in the treatment of disease 上海科技大学 2022-06-10 CN disclosed
CN-113603890-A Silicon-containing macromolecular visible photoinitiator 管和平 2021-11-05 CN disclosed
WO-2021078301-A1 PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF DISEASES 上海科技大学 2021-04-29 WO disclosed
CN-112707900-A Protein degradation agent and application thereof in disease treatment 上海科技大学 2021-04-27 CN disclosed
US-20200354220-A1 COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS NANOCORE APS (DK) 2020-11-12 US disclosed
EP-0172450-A2 Polymer compositions with liquid crystalline phases MERCK PATENT GmbH (DE) 1986-02-26 EP disclosed
US-4411903-A 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents AMERICAN CYANAMID COMPANY (US) 1983-10-25 US disclosed
US-4397757-A HYDROGEN PEROXIDE BLEACHING SYSTEM LEVER BROTHERS COMPANY (US) 1983-08-09 US disclosed
US-4311846-A 4-[(Monosubstituted-alkyl) amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents AMERICAN CYANAMID COMPANY (US) 1982-01-19 US disclosed
US-4245097-A 4-[(Monosubstituted-alkyl) amino] benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents AMERICAN CYANAMID COMPANY (US) 1981-01-13 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed
US-4154756-A HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1979-05-15 US disclosed
US-4110443-A INSECTICIDAL O,S-DIHYDROCARBYL-N-HALOACYLPHOSPHOROAMIDOTHIOATES AND S,S-DIHYDROCARBYL-N-HALOACYLPHOSPHOROAMIDODITHIOATES CHEVRON RESEARCH COMPANY (US) 1978-08-29 US disclosed
US-4049679-A Insecticidal O,S-dihydrocarbyl-N-haloacylphosphoroamidothioates and S,S-dihydrocarbyl-N-haloacylphosphoroamidodithioates CHEVRON RESEARCH COMPANY (US) 1977-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12103909-B2 Polycyclic aromatic hydrocarbon-based compounds for molecular electronic device and molecular electronic devices comprising same AHR, TRPA1, PAH TSHR 3840/4885ALDH1A1 1423/4885TP53 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.